Drug toxicity or syndrome of immune restoration causing fulminant cirrhosis after HAART-induced immune recovery

被引:5
作者
Murcia, JM [1 ]
Boix, V [1 ]
Merino, E [1 ]
Manso, MI [1 ]
Portilla, J [1 ]
机构
[1] Gen Hosp Univ Alicante, Infect Dis Unit, E-03080 Alicante, Spain
关键词
D O I
10.1007/s10096-001-0675-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:153 / 155
页数:3
相关论文
共 11 条
[1]   Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].
Benhamou, Y ;
Bochet, M ;
Di Martino, V ;
Charlotte, F ;
Azria, F ;
Coutellier, A ;
Vidaud, M ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (04) :1054-1058
[2]   Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway [J].
Brinkman, K ;
ter Hofstede, HJM ;
Burger, DM ;
Smeitinkt, JAM ;
Koopmans, PP .
AIDS, 1998, 12 (14) :1735-1744
[3]   Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? [J].
John, M ;
Flexman, J ;
French, MAH .
AIDS, 1998, 12 (17) :2289-2293
[4]   Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy [J].
Martínez, E ;
Blanco, JL ;
Arnaiz, JA ;
Pérez-Cuevas, JB ;
Mocroft, A ;
Cruceta, A ;
Marcos, MA ;
Milinkovic, A ;
García-Viejo, MA ;
Mallolas, J ;
Carné, X ;
Phillips, A ;
Gatell, JM .
AIDS, 2001, 15 (10) :1261-1268
[5]  
Nelson DR, 1997, J IMMUNOL, V158, P1473
[6]   Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment [J].
Puoti, M ;
Gargiulo, F ;
Roldan, EQ ;
Chiodera, A ;
Palvarini, L ;
Spinetti, A ;
Zaltron, S ;
Putzolu, V ;
Zanini, B ;
Favilli, F ;
Turano, A ;
Carosi, G .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :2033-2036
[7]   Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy [J].
Ragni, MV ;
Bontempo, FA .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :2027-2029
[8]   Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV [J].
Rutschmann, OT ;
Negro, F ;
Hirschel, B ;
Hadengue, A ;
Anwar, D ;
Perrin, LH .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :783-785
[9]   Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection [J].
Sulkowski, MS ;
Thomas, DL ;
Chaisson, RE ;
Moore, RD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (01) :74-80
[10]   Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects [J].
Zylberberg, H ;
Chaix, ML ;
Rabian, C ;
Rouzioux, C ;
Aulong, B ;
Bréchot, C ;
Viard, JP ;
Pol, S .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1104-1106